drugset / Trial / NCT01089140
Non-Idiopathic Scoliosis Treated With Tranexamic Acid
RandomizedFactorialDouble-blindTreatment
Summary
Investigation of tranexamic acid (TXA) for reducing perioperative blood loss and transfusion requirement in pediatric patients with secondary scoliosis undergoing posterior spinal fusion.
Timeline
- Start
- 2014-11
- Primary completion
- 2014-11
- Completion
- 2014-11
Outcome
Outcome not reported
Stopped: “Inadequate number of potential participants”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | — |
| Subject | Tranexamic Acid | Small molecule | 100 mg/kg | — |